Got Approval… Now What? Meeting Cell Therapy Market Demand

Invetech breakfast briefing at Phacilitate 2020

The commercial success of a cell-based therapeutic depends on a scalable, automated manufacturing process. But how can companies ensure their manufacturing processes are up to meeting the needs and market demand of the rapidly evolving cell therapy field?  Our annual breakfast briefing at the Phacilitate Leaders World conference in Miami tackled this and other current topics with a panel of industry luminaries.

David Hodl, Invetech’s Head of Business Development, Cell Therapy who chaired the panel, opened the discussion by highlighting one of the prevalent topics of the conference: how to scale up. With the Alliance for Regenerative Medicine estimating up to half a million patients in the US alone in the coming years, how can cell therapy companies meet market demand?